OPA1 and Parkinson disease: Previous analysis of patient-derived iPSCs carrying an OPA1 variant, associated with Parkinson's disease, showed that when differentiated into dopaminergic neurons or into NPCs they demonstrated significant reductions in basal respiration, maximal respiration and ATP output for haploinsufficient variant cells when compared to WT controls (49,51).